Novavax 96.4% effective against original variant of COVID
Health
- 12 March, 2021
- 06:26
The Novavax coronavirus vaccine proved 96.4 percent effective against the original variant of coronavirus and 86.3 percent effective against its British strain, Report informs, referring to RIA Novosti.
The third phase of the NVX CoV2373 vaccine trial took place in the UK. The study covered more than 15,000 participants aged 18-84, 27 percent of them were over 65.
The company also said that when it comes to severe form of COVID, the vaccine has demonstrated 100 percent effectiveness.
Latest News
08:31
President Vucic confirms plans to organize parliamentary elections in Serbia in 2026
Other countries08:23
Comex silver futures climb to new all-time high of over $82 per troy ounce
Finance08:13
Trump describes his phone call with Putin, meeting with Zelenskyy as excellent
Other countries17:51
Azerbaijan's traffic police issue advisory to drivers planning trips to mountainous districts
Incident17:43
Zelenskyy says significant developments possible before New Year
Other countries17:29
China connects world's largest offshore solar power plant to national grid
Other countries17:11
Winterstorm leaves over 160,000 households without power in Finland
Other countries17:00
Bayraktar KIZILELMA fighter drone completes successful test flight
Region16:16